Last reviewed · How we verify
NCT07018687: NUTRI-CARE
Improvement of Nutritional Status in Cancer Patients and Reduction of Malnutrition
NA trial testing day hospital in Cancer in 306 participants. Participants enrolled and being followed up; not accepting new ones.
8 April 2025
Quick facts
| Lead sponsor | Médipôle Lyon-Villeurbanne |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 306 |
| Start date | 30 July 2021 |
| Primary completion | 8 April 2025 |
| Estimated completion | 8 April 2026 |
| Sites | 1 location across France |
Drugs / interventions tested
- day hospital
- dietician consultation
Conditions studied
- Cancer — all drugs for Cancer →
Sponsor
Médipôle Lyon-Villeurbanne
Who can join
18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The European Society for Clinical Nutrition and Metabolism (ESPEN) recommends assessing the nutritional status of each oncology patient early and in a multidisciplinary manner. This assessment should take into account physical activity and should allow for the patient to be provided with nutritional goals adapted to their new needs. These recommendations aim to combat malnutrition, which sometimes leads to treatment suspension and thus a loss of opportunity for the patient.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07018687
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Médipôle Lyon-Villeurbanne trials
Trials by the same sponsor.
- NCT06600555 — Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes · NA · recruiting
- NCT07041710 — Rehabilitation of Taste and Smell Disorders Associated With Chemotherapy Using Aromatherapy · NA · recruiting
- NCT07439081 — OPTIMUM Study of Remote Patient Monitoring in Ambulatory Heart Failure Care · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07018687 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Médipôle Lyon-Villeurbanne
- Last refreshed: 12 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07018687.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing